Cnidium 川芎

Pharmaceutical nameCnidii Rhizoma

Evidence grade: Not gradedSafety signal: Adverse-event literature existsMapping confidence: Strong correspondence

The three axes are assessed independently and are never combined into a single score.

KTKP records the origin species as Cnidium officinale Makino. It has not yet been cross-checked against the Korean Pharmacopoeia, so the identification confidence is not raised to an official code mapping. The same drug appears under 5 records as name variants. The same source species also yields 1 other separately registered drug(s) (Cnidii Surculus), which must not be conflated. The name most used for this taxon in current literature is Cnidium officinale.

Tradition · what the text describes

탕액편

The sub-section within this volume has not been verified against the original text yet.

The KTKP traditional materia medica record (M0003618) gives the origin species as Cnidium officinale Makino, the part used as 뿌리줄기, and the properties as 무독(無毒), 신(辛), 온(溫). It lists 간(肝), 담(膽), 심포(心包) as the channels entered. The same record cites the Donguibogam (1613) as the source for its indications.

Properties & channel entry: 무독(無毒), 신(辛), 온(溫) · 간(肝), 담(膽), 심포(心包)

Source species: Cnidium officinale Makino (뿌리줄기)

Read the original: Korean Medicine Classics DB

Modern · documented evidence

(no indication derived — herb-name-only search)evidence for this indication

Evidence grade: Not graded
  • No indication is specified. A and B grades cannot be assigned until the query is narrowed to a specific indication.
  • No indication could be derived: no condition appears on two or more registered trials for this herb.

Literature

SR 1 · RCT 0 · preclinical 36

These counts come from a herb-name-only search (1 systematic reviews, 0 RCTs). Without a specific indication they show how much the herb has been studied, not what it works for.

Query used

We publish the exact query behind these counts so you can reproduce them yourself.

SRC:MED AND ((TITLE_ABS:"Cnidium officinale"))

Clinical trials

  • No registered trials.

Safety

auto-proposed · unreviewed

  • 2 adverse-event or toxicity record(s) were found. This only flags that literature exists — read the abstracts to decide between "caution" and "harm confirmed".
  • The KTKP record states the following traditional contraindication: 음허화왕자(陰虛火旺者)와 상성하허(上盛下虛) 및 기약자(氣弱者)는 복용(服用)을 기(忌)한다.

Adverse-event and toxicity literature

This is not a finding of harm — it lists literature that is retrievable. Read the papers to decide.

Sources